Amlodipine/Valsartan/Hydrochlorothiazide "Krka" 10+160+12,5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

amlodipine/valsartan/hydrochlorothiazide "krka" 10+160+12,5 mg filmovertrukne tabletter

krka d.d. novo mesto - amlodipinbesilat, hydrochlorthiazid, valsartan - filmovertrukne tabletter - 10+160+12,5 mg

Diovan 160 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan 160 mg filmovertrukne tabletter

novartis healthcare a/s - valsartan - filmovertrukne tabletter - 160 mg

Diovan 320 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan 320 mg filmovertrukne tabletter

novartis healthcare a/s - valsartan - filmovertrukne tabletter - 320 mg

Diovan 40 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan 40 mg filmovertrukne tabletter

novartis healthcare a/s - valsartan - filmovertrukne tabletter - 40 mg

Diovan 80 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan 80 mg filmovertrukne tabletter

novartis healthcare a/s - valsartan - filmovertrukne tabletter - 80 mg

Entresto Den Europæiske Union - dansk - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.